Transurethral resection, neoadjuvant chemotherapy and accelerated hyperfractionated radiotherapy (concomitant boost), with or without concurrent cisplatin, for patients with invasive bladder cancer – clinical outcome

AIM OF THE STUDY: To evaluate the toxicity, clinical effectiveness and survival rate of transurethral resection, neoadjuvant chemotherapy and accelerated hyperfractionated radiotherapy (concomitant boost), with or without concurrent cisplatin in patients with muscle invasive bladder cancer. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowak-Sadzikowska, Jadwiga, Jakubowicz, Jerzy, Skóra, Tomasz, Pudełek, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2013
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934068/
https://www.ncbi.nlm.nih.gov/pubmed/24596519
http://dx.doi.org/10.5114/wo.2013.35276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934068/
https://www.ncbi.nlm.nih.gov/pubmed/24596519
http://dx.doi.org/10.5114/wo.2013.35276

Ejemplares similares